(Stroke. 1996;27:2204-2206.)
© 1996 American Heart Association, Inc.
Articles |
the Department of Neurology, Tel Aviv Medical Center, and the Faculty of Sackler Medicine, Tel Aviv University, Israel.
Correspondence to N.M. Bornstein, MD, Stroke Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, 6 Weizmann St, Tel Aviv 64239, Israel.
| Abstract |
|---|
|
|
|---|
Methods Consecutive patients (n=182) with acute IS were examined within 48 hours after admission to our center. A history of acute infections within 2 months before the IS was assessed by means of a specially designed questionnaire that was also given to a control group consisting of 194 consecutive patients who were seen in our outpatient clinic and had suffered IS at least 6 months previously.
Results The prevalence of acute infection in the study group was significantly higher (44193/=24.2%) than in the control group (19193/=9.7%; odds ratio, 2.93; 95% confidence interval, 1.64 to 5.26; P=.0002) and infection occurred mostly within 1 week before the IS (41/44). Neither the severity of the IS nor the type of the infection was significantly different in patients and control subjects.
Conclusions Acute infections of different types constitute a risk factor for IS, particularly within 1 week of the event. However, the severity of the stroke is not related to this factor.
Key Words: cerebral ischemia epidemiology infection risk factors
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
Data are given as mean±SD for continuous variables, proportions, and OR estimates and 95% CI. Statistical analysis was performed with
2 analysis and t tests as appropriate.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
When all the subjects were analyzed together, infection was shown to have increased the risk of IS in all previously studied groups.1 2 3 4 8 Infections among our patients were mainly of bacterial origin. Recent studies2 3 4 on the possible mechanisms of infection-associated stroke revealed that there was significant elevation in peripheral blood of interleukin-1 and interleukin-6 and inhibition of polymorphonuclear activity. In a small series of stroke patients who had an associated infection, increased levels of TNF-
were detected, and TNF-
was suspected as a potential mediator in infection-associated stroke. Other factors have been studied, including common and specific pathways of induction of the endothelial adhesion proteins (ICAM-1, VCAM-1, and E-selectin). Differences in the kinetics of endothelial expression of E-selectin, VCAM-1, and ICAM-1 may also contribute to the selective recruitment of leukocyte subtypes to the site of inflammation. Combinations of cytokines may produce additive or synergistic (eg, interleukin-4 and TNF-
for VCAM-1) or antagonistic (eg, interleukin-4 and TNF-
for E-selectin) effects. These multiple levels of regulation provide for precise modulation of expression of endothelial adhesion proteins that are involved in recruitment of leukocytes to sites of inflammation. Another possible coagulative mechanism that may be a relevant factor in IS triggered by infection is an increase of fibrinogen concentration during infection, which increases the blood viscosity.2 3 4 5 12 16 Other authors did not find differences in the severity of the neurological deficit between patients with and without prior infections,2 8 and neither the severity of the IS nor the type of the bacterial infection was significantly different in our two groups (Table 4
).
In summary, acute infection of different types constitutes a risk factor for IS, particularly during the first week of the disease. However, the severity of the stroke was apparently not related to this factor. The retrospective ascertainment of the type of infection may of course lead to inaccuracies. However, we do not think that recall bias or differences in motivation could explain the results, particularly the strikingly high frequency of infections during the week preceding the infection.
| Selected Abbreviations and Acronyms |
|---|
|
Received May 17, 1996; revision received September 9, 1996; accepted September 16, 1996.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. R. Tso, J. G. Merino, and S. Warach Interleukin-6 174G/C Polymorphism and Ischemic Stroke: A Systematic Review Stroke, November 1, 2007; 38(11): 3070 - 3075. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kazanci, K. K. Oguz, A. Gurgey, and M. Topcu Streptococcus oralis as a Risk Factor for Middle Cerebral Artery Thrombosis J Child Neurol, July 1, 2005; 20(7): 611 - 613. [Abstract] [PDF] |
||||
![]() |
J.A. Zeller, A. Lenz, C.C. Eschenfelder, P. Zunker, and G. Deuschl Platelet-Leukocyte Interaction and Platelet Activation in Acute Stroke With and Without Preceding Infection Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1519 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Grau, B. Fischer, C. Barth, P. Ling, C. Lichy, and F. Buggle Influenza Vaccination Is Associated With a Reduced Risk of Stroke Stroke, July 1, 2005; 36(7): 1501 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A Zeller, K Frahm, R Baron, R Stingele, and G Deuschl Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 984 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lindsberg and A. J. Grau Inflammation and Infections as Risk Factors for Ischemic Stroke Stroke, October 1, 2003; 34(10): 2518 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Guillon, K. Berthet, L. Benslamia, M. Bertrand, M.-G. Bousser, and C. Tzourio Infection and the Risk of Spontaneous Cervical Artery Dissection: A Case-Control Study Stroke, July 1, 2003; 34 (7): e79 - e81. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly N. Engl. J. Med., April 3, 2003; 348(14): 1322 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Paganini-Hill, E. Lozano, G. Fischberg, M. Perez Barreto, K. Rajamani, S.F. Ameriso, P.N.R. Heseltine, and M. Fisher Infection and Risk of Ischemic Stroke: Differences Among Stroke Subtypes Stroke, February 1, 2003; 34(2): 452 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lavallee, V. Perchaud, M. Gautier-Bertrand, D. Grabli, and P. Amarenco Association Between Influenza Vaccination and Reduced Risk of Brain Infarction Stroke, February 1, 2002; 33(2): 513 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kent, V. M. Soukup, and R. H. Fabian Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse Stroke, October 1, 2001; 32(10): 2318 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Napoli, F. Papa, and V. Bocola C-Reactive Protein in Ischemic Stroke : An Independent Prognostic Factor Stroke, April 1, 2001; 32(4): 917 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lanska and R. J. Kryscio Risk Factors for Peripartum and Postpartum Stroke and Intracranial Venous Thrombosis Stroke, June 1, 2000; 31(6): 1274 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Glader, B. Stegmayr, J. Boman, H. Stenlund, L. Weinehall, G. Hallmans, and G. H. Dahlen Chlamydia pneumoniae Antibodies and High Lipoprotein(a) Levels Do Not Predict Ischemic Cerebral Infarctions : Results From a Nested Case-Control Study in Northern Sweden Stroke, October 1, 1999; 30(10): 2013 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lanska and R. G. Hoffmann Seasonal variation in stroke mortality rates Neurology, March 1, 1999; 52(5): 984 - 984. [Abstract] [Full Text] |
||||
![]() |
L. Pantoni, C. Sarti, and D. Inzitari Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 503 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Grau, F. Buggle, C. Ziegler, W. Schwarz, J. Meuser, A.-J. Tasman, A. Buhler, C. Med, C. Benesch, H. Becher, et al. Association Between Acute Cerebrovascular Ischemia and Chronic and Recurrent Infection Stroke, September 1, 1997; 28(9): 1724 - 1729. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |